{
    "clinical_study": {
        "@rank": "119484", 
        "arm_group": [
            {
                "arm_group_label": "Nutrition bar", 
                "arm_group_type": "Placebo Comparator", 
                "description": "50 g nutrition bar"
            }, 
            {
                "arm_group_label": "Nutrition Bar 1", 
                "arm_group_type": "Experimental", 
                "description": "50 g nutrition bar with additional 2 g of milk-based nutrient"
            }, 
            {
                "arm_group_label": "Nutrition bar 2", 
                "arm_group_type": "Experimental", 
                "description": "50 g nutrition bar with additional  3 g of milk-based nutrient"
            }
        ], 
        "brief_summary": {
            "textblock": "This study investigates nutrition bar consumption and possible impact on self-reported\n      ratings of hunger and fullness compared to a control."
        }, 
        "brief_title": "Effect of Nutrition Bars on Satiety in Women", 
        "condition": [
            "Hunger", 
            "Satiety"
        ], 
        "detailed_description": {
            "textblock": "Participant eligibility will be screened at visit 1. Test days will commence at 8 to 10 a.m.\n      and visits two to four will be spaced four days apart. On visit days participants consume a\n      nutrition bar; satiety and hunger ratings, blood samples are collected simultaneously over a\n      three hour period. After completion, participants will complete gastrointestinal (GI)\n      tolerability as well as Palatability and Adverse Events questionnaires."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Premenopausal women\n\n          -  Body mass index (BMI) 20.00-29.99 kg/m2\n\n          -  Maintenance of habitual diet, physical activity patterns, and body weight throughout\n             the trial\n\n          -  In general good health on the basis of medical history; and taking no medication\n             other than birth control, hormone replacement therapy, statins or blood pressure\n             medication\n\n          -  Participant understands the study procedures, provides signed informed consent to\n             participate in the study and authorization for release of relevant protected health\n             information to the study investigator.\n\n          -  Participant can consume a nutrition bar in the allotted time frame\n\n        Exclusion Criteria:\n\n          -  Use of over-the-counter weight-loss drugs and herbal remedies or supplements and\n             dieting programs/behavior (within two months of visit 1)\n\n          -  Variation in body weight >8.8 lbs. (4 kg) within the previous three month before\n             screening\n\n          -  Any history of an eating disorder (e.g., anorexia nervosa, bulimia nervosa, binge\n             eating) diagnosed by a health professional\n\n          -  Subject scores \u226514 on restraint factor of the Three-Factor Eating Questionnaire\n\n          -  History or presence of clinically important renal or gastrointestinal  disorders, or\n             diabetes mellitus\n\n          -  Extreme dietary habits (e.g. vegan, Atkins diet, exclusion of major food groups,\n             etc.)\n\n          -  History of allergy, sensitivity, or strong dislike towards any of the components of\n             the study products\n\n          -  Females who are pregnant, or planning to be pregnant during the study period or\n             lactating\n\n          -  Use of an investigational drug product within the last 30 days\n\n          -  Individual has a condition the Investigator believes would interfere with her ability\n             to provide informed consent, comply with the study protocol, or which might confound\n             the interpretation of the study results or put the person at undue risk.\n\n          -  Subject does not understand English."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "42", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 11, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02091570", 
            "org_study_id": "PEP-1308"
        }, 
        "intervention": {
            "arm_group_label": [
                "Nutrition bar", 
                "Nutrition Bar 1", 
                "Nutrition bar 2"
            ], 
            "description": "Intervention involves consumption of one nutrition bar of approximately 50 g in the beginning of each visit of the crossover sequence", 
            "intervention_name": "Nutrition Bar", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Hunger", 
            "Fullness", 
            "Satiety", 
            "Nutrition bar", 
            "Crossover"
        ], 
        "lastchanged_date": "March 18, 2014", 
        "location": {
            "contact": {
                "email": "alexandrajenkins@gilabs.com", 
                "last_name": "Alexandra Jenkins", 
                "phone": "(416) 861-9782"
            }, 
            "facility": {
                "address": {
                    "city": "Toronto", 
                    "country": "Canada", 
                    "state": "Ontario", 
                    "zip": "M5C 2N8"
                }, 
                "name": "Glycemic Index Laboratories"
            }, 
            "investigator": {
                "last_name": "Thomas Wolever, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "3", 
        "official_title": "A Randomized, Controlled, Double-Blind Crossover Pilot Trial to Assess the Effects of Nutrition Bars on Subjective Ratings of Hunger and Fullness in Women", 
        "overall_contact": {
            "email": "alexandrajenkins@gilabs.com", 
            "last_name": "Alexandra Jenkins, PhD", 
            "phone": "(416) 861-9782"
        }, 
        "overall_official": [
            {
                "affiliation": "PepsiCo, Inc.", 
                "last_name": "Douglas Bolster, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "PepsiCo, Inc.", 
                "last_name": "Laura Harkness, PhD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Canada: WIRB", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "change in self-reported hunger or fullness compared to placebo", 
            "measure": "self-reported hunger and fullness rating", 
            "safety_issue": "No", 
            "time_frame": "3 hour period after consumption of study product, on 3 occasions"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02091570"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "change in analyte concentrations compared to placebo", 
            "measure": "blood sample analytes", 
            "safety_issue": "No", 
            "time_frame": "3 hour period after consumption of study product, on 3 occasions"
        }, 
        "source": "PepsiCo Global R&D", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "PepsiCo Global R&D", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}